CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Originaltitel der Bekanntmachung
Malta – Toxins – CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
45 / 100
Risikofaktoren
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- EUR 5.6M estimated value
- Supplies contract
- 1 lot
- Supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for Inflammatory Bowel Disease (IBD)
- Framework contract; no quantities or minimum spend specified
Vollständige Zusammenfassung anzeigen
This is an open procedure framework contract for the supply of selective Janus Kinase 1 inhibitor tablets/prolonged release tablets/capsules for inflammatory bowel disease (IBD). The contract is for a single lot with an estimated total value of €5,608,254.60. The buyer is the Department of Contracts in Malta. The deadline for submission is 15 July 2026 at 07:30 (Malta time). Electronic submission is required in English. The notice does not disclose award or selection criteria; only an ESPD (European Single Procurement Document) is referenced. No procurement documents were analyzed beyond the notice.
Risiken
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Must supply pharmaceutical products classified under CPV 33693100
Administrative
- Electronic submission via eTenders Malta portal
- Tender must be submitted in English
Anforderungen können unvollständig sein.
Auftraggeber
Ort
Floriana, MLT
Website
Auftraggeberprofil
Kennung
MT25645419
Tätigkeit
General public services
Lose (1)
LOT-0001
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Supply of selective JAK1 inhibitor tablets/prolonged release tablets/capsules for IBD.
EUR 5.6M
Geschätzter Wert
Ort
Kategorie
Frist
Zuschlagsdetails
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
CT2211/2026 - Framework Contract for the supply of Selective Janus Kinase 1 Inhibitor Tablets/Prolonged Release Tablets/Capsules for IBD
Vergabedetails
- Veröffentlichungsdatum
- 10 Jun 2026
- Sprachen
- English
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 400302-2026
Dokumente (2)
Opportunity Score
Warum diese Bewertung?
Chance
60 / 100
Komplexität
45 / 100
Risikofaktoren
Award criteria and selection criteria are not disclosed, making bid preparation speculative.
Framework contract may not guarantee any minimum purchase volume.
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications